This story was originally published Oct. 8.

Researchers at MD Anderson Cancer Center's Institute for Personalized Cancer Therapy have begun a two-tiered sequencing protocol for cancer patients in order to guide treatment and identify eligible clinical trials.

Patient samples are initially sequenced in a CLIA-certified setting on the Ion Torrent PGM, Funda Meric-Bernstam, the medical director of MD Anderson's Institute for Personalized Cancer Therapy, explained at BGI's International Conference of Genomics meeting in Philadelphia this month.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.